Brookline Capital Initiates Quince Therapeutics(QNCX.US) With Buy Rating, Announces Target Price $9

Moomoo NewsDec 19 05:33 ET · Ratings

Quince Therapeutics Files Mixed Securities Shelf; Shares Rise After Hours

MT NewswiresDec 18 17:48 ET

Express News | Quince Therapeutics: Files for Mixed Shelf Offering of up to $200 Mln - SEC Filing

ReutersDec 18 16:04 ET

This Box Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday

BenzingaDec 18 10:03 ET

Brookline Capital Initiates Coverage On Quince Therapeutics With Buy Rating, Announces Price Target of $9

BenzingaDec 18 07:48 ET · Ratings

Quince Therapeutics Analyst Ratings

BenzingaDec 18 07:45 ET · Ratings